IM Therapeutics launches to advance therapies for treating Type 1 diabetes

IM Therapeutics launches to advance therapies for treating Type 1 diabetes

BROOMFIED -- ImmunoMolecular Therapeutics (IM Therapeutics) , a company developing personalized small molecule therapies for the treatment of genetically defined autoimmune diseases, today made... Read More

Thursday November 9, 2017 0 comments Tags: Broomfield, IM Therapeutics, Peter Gottlieb, Aaron Michels, Steve Orndorff, Greg Kading, Type 1 diabetes